Veerhealth Care Ltd.
Snapshot View

View in App

Prices View details >>

17.25 -0.25 ▼-1.4%

21 March 2023, 04:01:00 PM
Volume: 4,021

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.veerhealthcare.net
Market Cap 17.25 Cr.
Enterprise Value(EV) 17.04 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.21 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 81.75 Trailing Twelve Months Ending 2022-12
Industry PE 31.71 Trailing Twelve Months Ending 2022-12
Book Value / Share 20.41 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.85 Calculated using Price: 17.25
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.00 Cr. 9,999,238 Shares
FaceValue 10
Company Profile
The company is engaged mainly in business of trading and investing in shares and securities.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.43%
1 Week
-6.71%
1 Month
-25.00%
3 Month
-23.84%
6 Month
+31.48%
1 Year
+53.33%
2 Year
+128.78%
5 Year
+23.66%
10 Year
-6.76%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 0.20 0.45 0.07 0.18 1.06 1.20 2.35 2.73 -0.53
Return on Capital Employed (%) 0.31 1.62 1.13 1.00 2.38 2.89 5.50 4.97 2.17
Return on Assets (%) 0.19 0.42 0.06 0.17 0.99 1.02 1.86 2.07 -0.38

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 13 13 13 13 13 13 14 14 14 14
Non Curr. Liab. 0 1 1 1 0 0 3 3 4 4
Curr. Liab. 0 1 1 0 1 3 1 2 2 2
Minority Int.
Equity & Liab. 13 14 14 13 15 16 18 19 20 20
Non Curr. Assets 8 6 7 5 8 13 12 12 14 14
Curr. Assets 5 8 7 8 7 3 6 7 6 6
Misc. Exp. not W/O 0 0
Total Assets 13 14 14 13 15 16 18 19 20 20

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 3 1 2 2 5 6 12 11 10 12
Other Income 1 0 0 1 1 0 0 1 2 1
Total Income 4 2 3 3 6 6 12 12 11 13
Total Expenditure -3 -1 -2 -2 -5 -6 -11 -11 -10 -12
PBIDT 0 0 0 0 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 -1 -1
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 1 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -7 4 -4 2 2 2 0 1 2
Cash Fr. Inv. 8 -4 4 0 0 -3 -2 -2 0 -1
Cash Fr. Finan. -1 1 0 2 -1 0
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 41.25 41.92 41.92 41.93 41.93 42.34 44.31 44.36 44.36
Public 58.75 58.08 58.08 58.07 58.07 57.66 55.69 55.64 55.64
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 10 Mar 2023
Board Meeting Outcome for Outcome Of Board Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. March 10 2023 as under:1. Allotment of 30 65 000 Equity Shares having face value of Rs. 10/- each at a premium of Rs. 9.25/- per Equity Share to Non-Promoters further in pursuance of resolution for preferential issue passed by the members at the Extra-Ordinary General Meeting held on 10th January 2023.The Company has received in principle approval from BSE Limited vide its letter no. LOD/PREF/VJ/FIP/3193/2022-23 dated 6th March 2023.The Board Meeting commenced at 11.00 a.m. and concluded at 11.45 a.m.
Mon, 06 Mar 2023
Board Meeting Intimation for Allotment Of Equity Shares On Preferential Basis To Non Promoters Of The Company.
Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/03/2023 inter alia to consider and approve Allotment of Equity Shares on preferential basis to Non Promoters of the Company.
Tue, 28 Feb 2023
Announcement Under Regulation 30 (LODR)-Order Of Condonation Of Delay
This is to inform that the Company has received an Order of condonation of delay from Securities and Exchange Board of India (SEBI) on 28th February 2023. Copy of the same is attached herewith.

Technical Scans View Details >>

Mon, 20 Mar 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at Low Opening at Low
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 230,636.07 956.20 -0.5%
Divi's Laboratories Ltd. 74,303.33 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. 73,967.90 4,419.30 -0.5%
Cipla Ltd. 70,000.14 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. 61,905.77 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. 51,514.78 1,518.00 -0.3%
Zydus Lifesciences Ltd. 48,165.73 477.95 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.76 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.06 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.25 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-12 26.53 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.95 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.90 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.34 477.95 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.17 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.35 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-12 3.08 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.07 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.79 477.95 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 0.04 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.95 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.95 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.95 +0.4%

FAQ's On Veerhealth Care Ltd.

What is Veerhealth Care share price?
Can I buy Veerhealth Care shares now?
What is the Market Cap of Veerhealth Care?
What are the key metrics to analyse Veerhealth Care?
What is the 52 Week High and Low of Veerhealth Care?
What is the trend of Veerhealth Care share price?